申请人:Taisho Pharmaceutical Co., Ltd
公开号:US07994204B2
公开(公告)日:2011-08-09
The present invention aims to provide compounds which have an inhibitory effect on the binding between S1P and its receptor Edg-1(S1P1) and which are useful for pharmaceutical purposes.
A compound represented by formula (I) or a pharmaceutically acceptable salt thereof:
[wherein Ar represents a monocyclic heterocyclic ring containing one or two nitrogen atoms, A represents an oxygen atom or the like, Y1, Y2 and Y3 each represent a carbon atom or a nitrogen atom, R1 represents a hydrogen atom, a C1-C6 alkyl group or the like, R2 represents a C1-C6 alkyl group, a C3-C8 cycloalkyl group or the like, R3 represents a C1-C18 alkyl group or the like, R4 represents a hydrogen atom or a C1-C6 alkyl group, and R5 represents a C1-C10 alkyl group or the like].
本发明旨在提供一种具有抑制S1P与其受体Edg-1(S1P1)结合的作用的化合物,并且对于制药目的有用。化合物由式(I)或其药学上可接受的盐表示:[其中Ar代表含有一个或两个氮原子的单环杂环,A代表氧原子或类似物,Y1、Y2和Y3分别代表碳原子或氮原子,R1代表氢原子、C1-C6烷基或类似物,R2代表C1-C6烷基、C3-C8环烷基或类似物,R3代表C1-C18烷基或类似物,R4代表氢原子或C1-C6烷基,R5代表C1-C10烷基或类似物]。